VIA
IONS icon

Victrix Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Victrix Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
+3,400
New +$256K 0.11% 67
2025
Q4 		– Sell
-3,400
Closed -$222K – 106
2025
Q3 		$222K Buy
+3,400
New +$166K 0.12% 67

Other funds holding IONS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Victrix Investment Advisors's IONS Position: Q2 2026 in Review

Victrix Investment Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 3,400 shares worth $270K. The stake represents 0.11% of the portfolio and ranks #67 among its holdings. This is a return to the name: Victrix Investment Advisors previously reported a position in IONS as recently as Q3 2025.

Victrix Investment Advisors first reported a position in IONS in Q3 2025 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Victrix Investment Advisors held 3,400 shares of Ionis Pharmaceuticals worth $270K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Victrix Investment Advisors position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.11% of Victrix Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Victrix Investment Advisors first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.